论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
绝经后女性全身免疫炎症水平极高会增加全因死亡率和心血管疾病死亡率的风险
Authors Wu F, Yang J, Liu Y, Zhang Y
Received 5 November 2024
Accepted for publication 11 May 2025
Published 20 May 2025 Volume 2025:17 Pages 1457—1468
DOI http://doi.org/10.2147/IJWH.S504664
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Vinay Kumar
Fei Wu,1 Jiantong Yang,1 Yinchuan Liu,1 Yipei Zhang2
1Department of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, 330006, People’s Republic of China; 2Department of Gynecology, Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, Jiangxi, 330008, People’s Republic of China
Correspondence: Yipei Zhang, Department of Gynecology, Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, Jiangxi, 330008, People’s Republic of China, Email 1113772944@qq.com
Background: The systemic immune inflammation (SII) index provides a comprehensive assessment of inflammatory and immune status in patients with different diseases. However, it remains unclear whether the SII can be considered a valuable prognostic risk factor of all-cause mortality for postmenopausal women.
Methods: We analyzed data from 1882 postmenopausal women enrolled in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. The Systemic Immune-Inflammation Index (SII) was calculated using peripheral blood cell counts and categorized into quartiles. Multivariable Cox proportional hazards models and restricted cubic spline analyses were employed to assess the association between SII and mortality outcomes.
Results: Over a median follow-up period of 8 years, 13.5% individuals died, with 4% deaths attributed to CVD. Patients with extremely high SII levels experienced significantly higher all-cause and CVD mortality. Compared to the low SII group (Q1), the hazard ratio (HR) and 95% confidence interval (CI) for all-cause mortality risk were 0.96 (0.87, 1.07), 0.97 (0.88, 1.08), and 1.28 (1.16, 1.41) for Q2, Q3, and Q4, respectively. Similarly, the HR (95% CI) for CVD mortality in Q2, Q3, and Q4 were 1.02 (0.83, 1.24), 1.11 (0.92, 1.34), and 1.32 (1.10, 1.58), respectively. Including SII in addition to traditional risk factors resulted in a slight enhancement in mortality prediction capability.
Conclusion: Among postmenopausal women, extremely high SII levels were identified as an independent risk factor for all-cause and CVD mortality.
Keywords: systemic immune inflammation, mortality, postmenopausal women, women health, cardiovascular disease